Orforglipron lowered A1C and body weight more than oral semaglutide 25 mg at 52 weeks, but the estimate comes from an indirect comparison.
|Articles|June 7, 2004
Chains work to keep e-health information from prying eyes
HIPAA's security standards will take effect in about a year and pharmacists are starting to conduct a risk analysis to prepare for the new requirements
Advertisement
Advertisement
Related to this article
Brian Smith, PharmD, explains how direct-to-consumer GLP-1 pathways broaden initial access but endanger long-term patient adherence.
Pharmacists face burnout and financial strain as PBMs take big cuts, prompting urgent calls for reform to protect patient care and community pharmacies.
What pharmacy technicians say would actually make them feel seen on World Pharmacy Technician Day, and the other 364 days of the year.
The analysis is not a head-to-head trial, and the weight loss gap reached statistical significance under 1 of 2 estimands.
A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
First approved for adults in 2022, the therapy is now cleared for adults and pediatric patients weighing 66 lbs or more with symptomatic obstructive hypertrophic cardiomyopathy.
Advertisement
Advertisement
Trending on Drug Topics
1
Technicians Aren't Asking for a Party
2
Indirect Comparison Links Tirzepatide to Greater Weight Loss Than Semaglutide
3
Burnout and PBMs Remain Barriers for Community Pharmacists
4
Infections Fall With Azithromycin for Unscheduled Cesarean Deliveries
5